Idexx Laboratories
IDXX
720 hedge funds and large institutions have $20.4B invested in Idexx Laboratories in 2019 Q3 according to their latest regulatory filings, with 71 funds opening new positions, 239 increasing their positions, 261 reducing their positions, and 63 closing their positions.
13% more first-time investments, than exits
New positions opened: 71 | Existing positions closed: 63
1% more funds holding
Funds holding: 715 → 720 (+5)
0.88% less ownership
Funds ownership: 87.95% → 87.07% (-0.88%)
2% less capital invested
Capital invested by funds: $20.8B → $20.4B (-$443M)
8% less repeat investments, than reductions
Existing positions increased: 239 | Existing positions reduced: 261
10% less funds holding in top 10
Funds holding in top 10: 21 → 19 (-2)
61% less call options, than puts
Call options by funds: $33.5M | Put options by funds: $86.4M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$105M |
| 2 |
BlackRock
New York
|
+$68.4M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$55.3M |
| 4 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$40.7M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$27.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MWNA
Marshall Wace North America
New York
|
-$92.4M |
| 2 |
Renaissance Technologies
New York
|
-$74M |
| 3 |
JIM
Jupiter Investment Management
London,
United Kingdom
|
-$60.6M |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$48.1M |
| 5 |
Neuberger Berman Group
New York
|
-$42.9M |
IDXX Hedge Fund Activity: Q3 2019 in Review
720 of the 4,574 institutional investors tracked by Wall St. Rank reported a position in Idexx Laboratories (IDXX) for Q3 2019, worth a combined $20.4B — down 2.1% from $20.8B a quarter earlier.
Buyers outnumbered sellers: 71 funds opened new IDXX positions and 63 closed out — a net gain of 8 holders — while 239 added to existing stakes and 261 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $105M. The largest seller was Marshall Wace North America, cutting an estimated $92.4M.
- 720 institutional investors held Idexx Laboratories (IDXX) as of Q3 2019, up from 715 in Q2 2019.
- Funds reported $20.4B of Idexx Laboratories stock for Q3 2019, down 2.1% quarter-over-quarter.
- 71 funds opened new Idexx Laboratories positions in Q3 2019 and 63 closed out, a net change of +8 holders.
- The largest Idexx Laboratories buyer in Q3 2019 was Fidelity Investments, an estimated $105M added.
- The largest Idexx Laboratories seller in Q3 2019 was Marshall Wace North America, an estimated $92.4M sold.
Based on aggregated 13F filings for Q3 2019.